Skip to main content
. 2016 Apr 28;11(6):4240–4244. doi: 10.3892/ol.2016.4508

Figure 2.

Figure 2.

Echocardiography and ECG examinations performed prior to erlotinib treatment. (A) Echocardiography performed on October 18, 2013, prior to the administration of targeted treatment. (B) ECG performed on April 14, 2014, prior to the administration of targeted treatment. ECG, electrocardiogram.